• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussion
  • Groups
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussion
    • Groups
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Type 1 Diabetes

    Can Stem Cell Therapy Disrupt Type 1 Diabetes Treatment Paradigm—or Even Cure the Disease University of Miami Launches a Study to Discover this Answer

    Can Stem Cell Therapy Disrupt Type 1 Diabetes Treatment Paradigm—or Even Cure the Disease? University of Miami Launches a Study to Discover this Answer

    University of Miami Miller School of Medicine clinical investigators from its Diabetes Research Institute and Vertex Pharmaceuticals initiated a potentially path breaking clinical trial for…

    TrialSite Staff
    TrialSite Staff April 7, 2021
    0 Comments
    Investigational Allogeneic Human Stem Cell Therapy for Type 1 Diabetics Awarded FDA Fast Track Designation While Phase 12 Clinical Trial Commences

    Investigational Allogeneic Human Stem Cell Therapy for Type 1 Diabetics Awarded FDA Fast Track Designation While Phase 1/2 Clinical Trial Commences

    VX-880, formerly known as STx-02, is an investigational allogeneic human stem cell-derived islet cell therapy that is being evaluated for patients who have type 1…

    TrialSite Staff
    TrialSite Staff March 11, 2021
    0 Comments
    Do Type 1 Diabetics Face Greater Risk with COVID-19? Disease Registry Study Used to Investigate

    Do Type 1 Diabetics Face Greater Risk with COVID-19? Disease Registry Study Used to Investigate

    T1D Exchange has launched a population health surveillance study of individuals with type diabetes (T1D) who are suspected or confirmed to have contracted COVID-19. The…

    TrialSite Staff
    TrialSite Staff April 11, 2020
    0 Comments
    Launch of the World’s First Artificial Pancreas App Developed at University of Cambridge

    Launch of the World’s First Artificial Pancreas App Developed at University of Cambridge

    The world’s first licensed, downloadable artificial pancreas app for those with type 1 diabetes was launched recently—based on the research of Professor Roman Hovorka with…

    TrialSite Staff
    TrialSite Staff March 17, 2020
    0 Comments
    Thymus Atlas Could Spark New Treatments for Cancer, Autoimmune Disease

    Thymus Atlas Could Spark New Treatments for Cancer, Autoimmune Disease

    Scientists have mapped the thymus, a gland in the chest that makes disease-fighting white blood cells, across the human life span. This “cell atlas” could…

    TrialSite Staff
    TrialSite Staff February 25, 2020
    0 Comments
    Boston College Researcher Receives Grant to Pursue Role of Gut Microbes in Type I Diabetes

    Boston College Researcher Receives Grant to Pursue Role of Gut Microbes in Type I Diabetes

    What roles do gut microbes and viruses play in triggering the autoimmunity of Type 1 diabetes? The G. Harold and Leila Y. Mathers Foundation would like…

    TrialSite Staff
    TrialSite Staff February 8, 2020
    0 Comments
    UNSW Sydney Receives World First Diabetic Research Study Following Babies from Pregnancy to Early Childhood

    UNSW Sydney Receives World First Diabetic Research Study Following Babies from Pregnancy to Early Childhood

    University of New South Wales (UNSW) Sydney, along with partners, have been awarded $8.25 million to further a study titled The Environmental Determinants of Islet Autoimmunity…

    TrialSite Staff
    TrialSite Staff January 25, 2020
    0 Comments
    UC Irvine & Start up Collaborate to Research Cell-Therapy-based Islet Transplantation for Type I Diabetes

    UC Irvine & Start up Collaborate to Research Cell-Therapy-based Islet Transplantation for Type I Diabetes

    University of California, Irvine (UCI) and its Clinical Islet Program led by Dr. Jonathan Lakey and Diomics Corporation, a leader in forensic, diagnostic and therapeutic…

    TrialSite Staff
    TrialSite Staff January 3, 2020
    0 Comments
    TEDDY Study Revealing Viruses in High Risk Children Linked to Type I Diabetes

    TEDDY Study Revealing Viruses in High Risk Children Linked to Type I Diabetes

    The Environmental Determinants of Diabetes in the Young (TEDDY) study is the largest prospective observational cohort study of newborns with increased genetic risk for Type 1…

    TrialSite Staff
    TrialSite Staff December 5, 2019
    0 Comments

    Hebrew University-Originated Artificial Pancreas Powers Jerusalem Startup Quest to Improve Diabetic Quality of Life

    Clinical investigative sponsors claim a breathing artificial pancreas, created using lung tissue from a pig, will commence in clinical trials within 12 months. It is…

    TrialSite Staff
    TrialSite Staff October 5, 2019
    0 Comments
    Load More

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.